Lymphoma - Clinical Research

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Cancer and Oncology


  • Lymphoma


The area of research for our group is malignant lymphomas – aiming for the improvement of the quality of life and survival of these patients. The paradigm behind most of current health care is evidence –based medicine. The evidence basis is primarily derived from clinical trials, but data can also be extracted from alternate sources such as national or regional data registries. The objective of our research is to expand this evidence basis, currently through three strategies: 1. The development of cIinical trials - we have been involved in all stages of trials for lymphoma, and designed, conducted and initiated several. 2. Clinical epidemiology – using data from the Swedish Lymphoma Registry to provide clinically useful real world data on treatment and prognosis, in many cases in collaboration with Nordic colleagues. 3. Translational research – to identify predictive biomarkers for treatment decision – by immunohistochemistry, gene expression or sequencing.

Recent research outputs

T. Wästerlid, Mohammadi, M., Smedby, K. E., Glimelius, I., M. Jerkeman, Bottai, M. & Eloranta, S., 2018 Oct 28, In : Journal of Internal Medicine.

Research output: Contribution to journalArticle

Hagström, H., Andreasson, A., Carlsson, A. C., Mats Jerkeman & Carlsten, M., 2018 Aug 23, In : PLoS ONE. 13, 8, e0202651

Research output: Contribution to journalArticle

Ekberg, S., Mats Jerkeman, Andersson, P. O., Enblad, G., Wahlin, B. E., Hasselblom, S., Andersson, T. M., Eloranta, S. & Smedby, K. E., 2018 Aug 1, In : American Journal of Hematology. 93, 8, p. 1020-1028 9 p.

Research output: Contribution to journalArticle

View All (37)